May 14, 2020 -- Applied DNA Sciences has received emergency use authorization from the U.S. Food and Drug Administration for a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.
The company's Linea COVID-19 RT-PCR test kit detects genetic sequences of SARS-CoV-2 from upper respiratory specimens. The assay runs on the Applied Biosystems QuantStudio Dx RT-PCR system, which can provide test results for up to 94 samples in one hour.
The RT-PCR was designed for CLIA-certified laboratories that require rapid, high-volume testing, according to the company. The product is now available for ordering.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current